{"id":481241,"date":"2020-04-24T15:06:01","date_gmt":"2020-04-24T15:06:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=481241"},"modified":"2020-04-24T15:06:01","modified_gmt":"2020-04-24T15:06:01","slug":"covid19-pipeline-analysis-and-assessment-of-products-in-different-clinical-stages","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/covid19-pipeline-analysis-and-assessment-of-products-in-different-clinical-stages_481241.html","title":{"rendered":"COVID-19: Pipeline analysis and assessment of products in different clinical stages"},"content":{"rendered":"
\"COVID-19:<\/a><\/p>\n
\n
COVID-19: Pipeline analysis <\/div>\n<\/div>\n<\/div>\n
The \u2018COVID-19 (CoronaVirus) – Pipeline Insight, 2020\u2019 report by DelveInsight offers a complete scenario of the R&D, development of therapies and diagnostic kits in the pipeline for COVID-19. At the moment, there is no cure for coronavirus. However, efforts, all over the world, are underway to find a standard cure for coronavirus.<\/div>\n

The ‘COVID-19(CoronaVirus) – Pipeline Insight, 2020<\/strong><\/a>’ report by DelveInsight<\/strong> offers a complete scenario of the R&D, development of therapies and diagnostic kits in the pipeline for COVID-19.<\/p>\n

Novel coronavirus SARS-CoV-2 has wreaked havoc in the whole world with total confirmed cases of 2,721,354 worldwide. Heavy restrictions, lockdowns, quarantines, and social distancing are the only measures that have been proved to manage and contain the spread.<\/p>\n

COVID-19 treatment approaches and COVID-19 pipeline landscape <\/strong><\/p>\n

At the moment, there is no cure for coronavirus. However, efforts, all over the world, are underway to find a standard cure for coronavirus.<\/p>\n

The report proffers insights into the present healthcare and pharma market scenario and shifted focus of the companies from their existing pipeline profile towards developing new treatment and preventive medicine against the novel SARS-CoV-2.<\/p>\n

The current COVID-19 pipeline includes several big and small pharma companies including Gilead Sciences<\/strong>, Sanofi<\/strong>, Vir Biotechnologies<\/strong>, Regeneron<\/strong>, Cipla<\/strong>, Abbvie<\/strong>, Roche<\/strong> among others developing novel treatment approaches as well as repurposing their existing anti-inflammatory drugs to tackle the viral outbreak. Companies such as GSK, Takeda, Moderna and others are already running pre-clinical or advanced phases of trials for their vaccines against SARS-CoV-2.<\/p>\n

Besides pharma companies, several healthcare institutions, hospitals, and universities including Columbian University<\/strong>, Stanford<\/strong>, Rutgers<\/strong>, Tongji Hospital<\/strong>, SouthWest Research Institute<\/strong> and others are aiding in developing the therapies to cure coronavirus infection.<\/p>\n

 <\/p>\n

\"\"<\/a><\/p>\n

Products covered by Phase<\/strong><\/p>\n